1. Home
  2. RPRX vs LUV Comparison

RPRX vs LUV Comparison

Compare RPRX & LUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • LUV
  • Stock Information
  • Founded
  • RPRX 1996
  • LUV 1967
  • Country
  • RPRX United States
  • LUV United States
  • Employees
  • RPRX N/A
  • LUV N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • LUV Air Freight/Delivery Services
  • Sector
  • RPRX Health Care
  • LUV Consumer Discretionary
  • Exchange
  • RPRX Nasdaq
  • LUV Nasdaq
  • Market Cap
  • RPRX 14.2B
  • LUV 14.7B
  • IPO Year
  • RPRX 2020
  • LUV N/A
  • Fundamental
  • Price
  • RPRX $34.02
  • LUV $32.68
  • Analyst Decision
  • RPRX Strong Buy
  • LUV Hold
  • Analyst Count
  • RPRX 4
  • LUV 16
  • Target Price
  • RPRX $42.50
  • LUV $30.67
  • AVG Volume (30 Days)
  • RPRX 3.9M
  • LUV 12.9M
  • Earning Date
  • RPRX 05-08-2025
  • LUV 04-23-2025
  • Dividend Yield
  • RPRX 2.59%
  • LUV 2.20%
  • EPS Growth
  • RPRX 37.60
  • LUV 37.74
  • EPS
  • RPRX 2.45
  • LUV 0.88
  • Revenue
  • RPRX $2,263,845,000.00
  • LUV $27,582,000,000.00
  • Revenue This Year
  • RPRX $31.16
  • LUV $3.57
  • Revenue Next Year
  • RPRX $5.86
  • LUV $6.78
  • P/E Ratio
  • RPRX $13.85
  • LUV $36.93
  • Revenue Growth
  • RPRX 1.13
  • LUV 3.25
  • 52 Week Low
  • RPRX $24.05
  • LUV $23.58
  • 52 Week High
  • RPRX $34.20
  • LUV $36.12
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 61.77
  • LUV 70.57
  • Support Level
  • RPRX $32.18
  • LUV $31.07
  • Resistance Level
  • RPRX $34.11
  • LUV $32.53
  • Average True Range (ATR)
  • RPRX 0.82
  • LUV 0.98
  • MACD
  • RPRX 0.09
  • LUV 0.50
  • Stochastic Oscillator
  • RPRX 91.93
  • LUV 97.86

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About LUV Southwest Airlines Company

Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated in a single, open-seating cabin configuration in a point-to-point network. In late 2025, Southwest will modify its cabins to offer some seats with extra legroom and will update its ticketing process to offer assigned seats.

Share on Social Networks: